Related Experiment Video

Updated: Jul 21, 2026

Profiling of Pre-micro RNAs and microRNAs using Quantitative Real-time PCR (qPCR) Arrays
10:58

Profiling of Pre-micro RNAs and microRNAs using Quantitative Real-time PCR (qPCR) Arrays

Published on: December 3, 2010

Hatteras rounds up $90 million to lead biotech rebound in North Carolina

Deborah Erickson

    Nature Biotechnology
    |November 7, 2015
    PubMed
    Abstract

    No abstract available in PubMed .

    More Related Videos

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    Related Experiment Videos

    Last Updated: Jul 21, 2026

    Profiling of Pre-micro RNAs and microRNAs using Quantitative Real-time PCR (qPCR) Arrays
    10:58

    Profiling of Pre-micro RNAs and microRNAs using Quantitative Real-time PCR (qPCR) Arrays

    Published on: December 3, 2010

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma
    06:15

    Tumor Treating Field Therapy in Combination with Bevacizumab for the Treatment of Recurrent Glioblastoma

    Published on: October 27, 2014

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
    10:27

    Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts

    Published on: July 25, 2020

    Related Concept Videos

    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...
    Targeted Cancer Therapies02:57

    Targeted Cancer Therapies

    The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
    There are several types of targeted therapies against specific...

    Articles linked to this work by shared authors, journal, and citation graph.

    Increasing HPV Vaccination Rates in the Primary Care Setting.

    Journal of doctoral nursing practice·2023

    Debriefing in the OR: A Quality Improvement Project.

    AORN journal·2019

    The Challenges of Interstitial Cystitis: Current Status and Future Prospects.

    Drugs·2015

    Diagnosis and treatment of interstitial cystitis/bladder pain syndrome: AUA guideline amendment.

    The Journal of urology·2015

    Diagnosis and treatment of arterial-ureteric fistula.

    Journal of vascular surgery·2013

    Barriers to physical activity in people with type 2 diabetes enrolled in a worksite diabetes disease management program.

    The Diabetes educator·2013

    Photolabile oligonucleotides with topological light gradients enable spatially resolved single-cell transcriptomics and epigenomics.

    Nature biotechnology·2026

    An engineered nanopore identifies saccharides, amino acids, peptides and ribonucleotides.

    Nature biotechnology·2026

    Integration of proteomic aging clocks in a phase 2a clinical trial supports simultaneous geroprotective assessment.

    Nature biotechnology·2026

    Engineered genomic attachment sites for site-specific recombinases enable high-efficiency integration in plants and human cells.

    Nature biotechnology·2026

    AI-enhanced adaptive virtual screening of large libraries for ligand discovery.

    Nature biotechnology·2026

    Commercial opposition and the politics of proof: Institutional design for regulatory durability in food and nutrition policy.

    Social science & medicine (1982)·2026

    Policy Standards for Healthy Built Environments: A Systematic Review of Health Impact Assessments and Nonrandomized Evaluations of Implemented Policies.

    Journal of urban health : bulletin of the New York Academy of Medicine·2026

    A research agenda for making evidence useful, usable and used in policymaking.

    Nature human behaviour·2026

    Perceived Social Connectedness and Substance Use among Adolescents and Young Adults in North Carolina.

    Prevention science : the official journal of the Society for Prevention Research·2026

    Reconciling fragmented sectors of health research regulation: toward an ecosystem of processual regulation.

    Humanities & social sciences communications·2026

    Historical Changes and Cross-Country Comparisons of Long-Term Care Policy: A New Resource.

    Journal of long-term care·2026
    See all related articles
    JoVE
    x logofacebook logolinkedin logoyoutube logo
    ABOUT JoVE
    OverviewLeadershipBlogJoVE Help Center
    AUTHORS
    Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
    LIBRARIANS
    TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
    RESEARCH
    JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
    EDUCATION
    JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
    Terms & Conditions of Use
    Privacy Policy
    Policies
    Jove
    Visualize
    Contact Us